Sarda Proteins Financials

BSE: 519242

₹92.66

₹-4.87 (-4.99%)

As on 31-Aug-2026IST

Market cap

₹83 Cr

Revenue (TTM)

₹18 Cr

P/E Ratio

31.6

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	18.20	24.19	1.30	5.80	10.76	11.36
Total Income	24.03	24.19	1.46	5.95	10.85	11.44
Total Expenditure	20.68	24.17	1.44	5.94	10.49	11.38
EBITDA	-2.49	0.02	-0.15	-0.15	0.27	-0.02
Depreciation	0.00	--	--	--	0.00	0.00
EBIT	-2.49	0.02	-0.15	-0.15	0.27	-0.02
Interest	--	0.00	0.00	0.00	0.00	0.00
Other Income	5.83	0.00	0.17	0.16	0.09	0.08
Exceptional Items	--	--	--	--	0.00	--
Profit before Tax	3.34	0.02	0.02	0.01	0.35	0.06
Provision for Tax	0.71	0.02	0.00	0.05	0.05	0.08
Profit after Tax	2.63	0.01	0.02	-0.03	0.31	-0.02

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	86.21	2.38	2.37	2.35	2.39	2.08
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	-0.09	-0.09	-0.11	-0.15	-0.21
Current Liabilities	0.45	0.24	0.02	0.02	0.04	0.03
Total Liabilities	86.66	2.65	2.43	2.40	2.45	2.13

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	--	--	0.00	0.00	0.00	0.01
Current Assets	86.53	2.53	2.30	2.27	2.27	1.90
Total Assets	86.66	2.65	2.43	2.40	2.45	2.13
Total Debt*	--	--	--	--	--	--
Net Current Assets	86.08	2.29	2.28	2.25	2.23	1.87
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	-0.11	-0.23	-0.30	0.10	-0.05
Cash Flow from Investing Activities	--	0.00	0.17	0.16	0.09	0.08
Cash from Financing Activities	--	0.03	0.00	--	0.00	0.00
Net Cash Inflow / Outflow	--	-0.08	-0.07	-0.14	0.19	0.03

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	7.48	0.03	0.11	-0.19	1.78	-0.12
Cash EPS (₹)	--	0.03	0.11	-0.19	1.78	-0.11
Adjusted Book Value (₹)	--	9.27	9.24	9.13	9.32	7.53
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.64	-1.34	-1.75	0.60	-0.30
Free Cash Flow per Share (₹)	--	-0.72	-0.38	-1.09	0.82	-0.23

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	0.86	0.80	0.55	15.81	3.00
ROE (%)	--	0.32	1.23	-2.08	21.15	-1.55
ROA (%)	5.89	0.21	0.85	-1.45	14.72	-1.08
EBIT Margin (%)	-13.68	0.08	-11.29	-2.53	2.51	-0.19
Net Margin (%)	10.95	0.02	1.33	-0.55	2.84	-0.18
Cash Profit Margin (%)	0.00	0.02	1.50	-0.57	2.86	-0.17

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-48.22	1,766.88	-77.64	-46.14	-5.28	110.35
EBIT Growth (%)	-535.20	113.60	0.35	-154.38	1,373.76	-122.39
Net Profit Growth (%)	749.88	-73.74	158.79	-110.74	1,616.40	-161.60
EPS Growth (%)	282.00	-73.78	158.78	-110.74	1,616.34	-161.62
Book Value Growth (%)	--	0.32	1.23	-2.05	23.65	-1.54

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	31.60	4,221.69	478.13	--	20.94	--
Price / Book Value	0.96	13.46	5.82	6.33	4.00	1.39
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	22.67	1,048.62	482.51	755.15	17.17	26.45
Close Price (₹)	93.13	124.75	53.79	57.76	37.30	10.46
High Price (₹)	144.30	124.75	78.51	330.70	57.75	10.46
Low Price (₹)	59.95	40.89	37.70	22.10	10.98	8.46
Market Cap (₹ Cr)	83.17	21.53	9.28	9.97	6.44	1.81

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	193.15	10.51	124.65	98.07	62.92	57.33
Quick Ratio	193.15	10.51	124.65	98.07	62.92	57.33
Interest Coverage	--	68.33	160.97	498.35	1,774.16	43.31

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	22.76	--	--	--	1.93	6.78
Asset Turnover	0.41	10.02	0.57	2.55	5.15	6.04
Receivable days	--	--	--	--	16.59	25.78
Inventory Days	--	--	--	--	--	--
Payable days	--	3.42	--	--	--	--
Cash Conversion Cycle	--	-3.42	--	--	--	25.78

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.